In summary, as an indicator of inflammation that increases with age, CRP can contribute to the development of NAFLD in aging by mediating insulin signaling, mitochondrial metabolism, and NF-κB signaling. Here, NFKB1 is linked to metabolic dysfunction-associated steatotic liver disease.